 SAN CLEMENTE, Calif.--BUSINESS WIRE--Glaukos Corporation NYSE: GKOS, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the following upcoming investor conferences: Berenberg U.S. CEO Conference on Thursday, November 12, 2020 one-on-one and group meetings only Stephens Annual Investment Conference on Thursda 